Clinical trial NCT00808301 - References

Clinical and Nutritional Safety. — Oat Products in the Treatment of Coeliac Disease in Children

Citation(s)

•   Arentz-Hansen H, Fleckenstein B, Molberg Ø, Scott H, Koning F, Jung G, Roepstorff P, Lundin KE, Sollid LM
  The molecular basis for oat intolerance in patients with celiac disease. PLoS Med. 2004 Oct;1(1):e1. Epub 2004 Oct 19.
•   Catassi C
  The world map of celiac disease. Acta Gastroenterol Latinoam. 2005;35(1):37-55. Review. English, Spanish.
•   Fasano A, Catassi C
  Current approaches to diagnosis and treatment of celiac disease: an evolving spectrum. Gastroenterology. 2001 Feb;120(3):636-51. Review.
•   Fasano A, Not T, Wang W, Uzzau S, Berti I, Tommasini A, Goldblum SE
  Zonulin, a newly discovered modulator of intestinal permeability, and its expression in coeliac disease. Lancet. 2000 Apr 29;355(9214):1518-9.
•   Garsed K, Scott BB
  Can oats be taken in a gluten-free diet? A systematic review. Scand J Gastroenterol. 2007 Feb;42(2):171-8. Review.
•   Hernando A, Mujico JR, Juanas D, Méndez E
  Confirmation of the cereal type in oat products highly contaminated with gluten. J Am Diet Assoc. 2006 May;106(5):665; discussion 665-6.
•   Hoffenberg EJ, Haas J, Drescher A, Barnhurst R, Osberg I, Bao F, Eisenbarth G
  A trial of oats in children with newly diagnosed celiac disease. J Pediatr. 2000 Sep;137(3):361-6.
•   Högberg L, Laurin P, Fälth-Magnusson K, Grant C, Grodzinsky E, Jansson G, Ascher H, Browaldh L, Hammersjö JA, Lindberg E, Myrdal U, Stenhammar L
  Oats to children with newly diagnosed coeliac disease: a randomised double blind study. Gut. 2004 May;53(5):649-54.
•   Hollén E, Högberg L, Stenhammar L, Fälth-Magnusson K, Magnusson KE
  Antibodies to oat prolamines (avenins) in children with coeliac disease. Scand J Gastroenterol. 2003 Jul;38(7):742-6.
•   Holm K, Mäki M, Vuolteenaho N, Mustalahti K, Ashorn M, Ruuska T, Kaukinen K
  Oats in the treatment of childhood coeliac disease: a 2-year controlled trial and a long-term clinical follow-up study. Aliment Pharmacol Ther. 2006 May 15;23(10):1463-72.
•   Janatuinen EK, Kemppainen TA, Julkunen RJ, Kosma VM, Mäki M, Heikkinen M, Uusitupa MI
  No harm from five year ingestion of oats in coeliac disease. Gut. 2002 Mar;50(3):332-5.
•   Lundin KE, Nilsen EM, Scott HG, Løberg EM, Gjøen A, Bratlie J, Skar V, Mendez E, Løvik A, Kett K
  Oats induced villous atrophy in coeliac disease. Gut. 2003 Nov;52(11):1649-52.
•   Peräaho M, Collin P, Kaukinen K, Kekkonen L, Miettinen S, Mäki M
  Oats can diversify a gluten-free diet in celiac disease and dermatitis herpetiformis. J Am Diet Assoc. 2004 Jul;104(7):1148-50.
•   Reunala T, Collin P, Holm K, Pikkarainen P, Miettinen A, Vuolteenaho N, Mäki M
  Tolerance to oats in dermatitis herpetiformis. Gut. 1998 Oct;43(4):490-3.
•   Størsrud S, Hulthén LR, Lenner RA
  Beneficial effects of oats in the gluten-free diet of adults with special reference to nutrient status, symptoms and subjective experiences. Br J Nutr. 2003 Jul;90(1):101-7.
•   Størsrud S, Olsson M, Arvidsson Lenner R, Nilsson LA, Nilsson O, Kilander A
  Adult coeliac patients do tolerate large amounts of oats. Eur J Clin Nutr. 2003 Jan;57(1):163-9.
•   Thompson T
  Gluten contamination of commercial oat products in the United States. N Engl J Med. 2004 Nov 4;351(19):2021-2.

Multicentre Clinical Trial on Oat Products in the Treatment of Coeliac Disease in Children

Details for clinical trial NCT00808301